Pure Biologics Spólka Akcyjna (PUR.WA)
PLN 15.22
(-8.86%)
PLN 15.22
(-8.86%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 12.85 Million PLN | 628.16% |
| 2022 | 1.76 Million PLN | -11.75% |
| 2021 | 2 Million PLN | -44.89% |
| 2020 | 3.62 Million PLN | 42.72% |
| 2019 | 2.54 Million PLN | 469.97% |
| 2018 | 446.11 Thousand PLN | 0.0% |
| 2017 | - PLN | 0.0% |
| 2016 | - PLN | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | - PLN | -100.0% |
| 2024 Q1 | 13.01 Million PLN | 2.33% |
| 2023 Q4 | 12.85 Million PLN | -66.47% |
| 2023 Q1 | 26.74 Million PLN | 1415.52% |
| 2023 FY | 12.85 Million PLN | 628.16% |
| 2023 Q2 | 38.89 Million PLN | 45.4% |
| 2023 Q3 | 38.33 Million PLN | -1.44% |
| 2022 Q4 | 1.76 Million PLN | 4.07% |
| 2022 Q3 | 1.69 Million PLN | -17.87% |
| 2022 FY | 1.76 Million PLN | -11.75% |
| 2022 Q2 | 2.06 Million PLN | -12.65% |
| 2022 Q1 | 2.36 Million PLN | 18.2% |
| 2021 Q2 | 2.21 Million PLN | -30.4% |
| 2021 FY | 2 Million PLN | -44.89% |
| 2021 Q4 | 2 Million PLN | -9.87% |
| 2021 Q3 | 2.21 Million PLN | 0.0% |
| 2021 Q1 | 3.18 Million PLN | -12.15% |
| 2020 Q4 | 3.62 Million PLN | -36.8% |
| 2020 FY | 3.62 Million PLN | 42.72% |
| 2020 Q3 | 5.74 Million PLN | 11.63% |
| 2020 Q1 | 2.45 Million PLN | -3.34% |
| 2020 Q2 | 5.14 Million PLN | 109.3% |
| 2019 Q2 | 1.51 Million PLN | -0.0% |
| 2019 FY | 2.54 Million PLN | 469.97% |
| 2019 Q4 | 2.54 Million PLN | -16.3% |
| 2019 Q3 | 3.03 Million PLN | 99.93% |
| 2019 Q1 | 1.51 Million PLN | 240.6% |
| 2018 Q3 | - PLN | 0.0% |
| 2018 FY | 446.11 Thousand PLN | 0.0% |
| 2018 Q1 | - PLN | 0.0% |
| 2018 Q4 | 446.11 Thousand PLN | 0.0% |
| 2017 FY | - PLN | 0.0% |
| 2017 Q4 | - PLN | 0.0% |
| 2016 FY | - PLN | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Bioceltix S.A. | 76.33 Thousand PLN | -16736.755% |
| BIOTON S.A. | 12.67 Million PLN | -1.38% |
| Captor Therapeutics Spolka Akcyjna | 1.24 Million PLN | -930.634% |
| Mabion S.A. | 2.94 Million PLN | -335.957% |
| Molecure S.A. | 4.97 Million PLN | -158.289% |
| NanoGroup S.A. | - PLN | -Infinity% |
| Pharmena S.A. | 114 Thousand PLN | -11173.684% |
| Poltreg S.A. | 7.8 Million PLN | -64.748% |
| Ryvu Therapeutics S.A. | 365 Thousand PLN | -3421.096% |
| Synthaverse S.A. | 61.2 Million PLN | 79.001% |
| Urteste S.A. | 312 Thousand PLN | -4019.231% |